Case Study
Unlocking Community Treaters at Scale
How an early access partner used Bionara to move from static KOL lists to a validated, data-driven provider universe — in days, not months.
The Problem
Limited visibility into the real treatment landscape
The team knew their biggest gap wasn't at the top of the funnel — they already had relationships with academic KOLs and specialists. The problem was everything below that.
The vast majority of patients in their therapeutic area were being managed by community treaters — providers who didn't show up on any existing list, weren't flagged by any database, and were completely invisible to traditional identification methods. The team had no systematic way to find them, validate them, or prioritize them.
What lists they did have were unreliable — full of false positives, skewed toward specialists, and built on assumptions rather than real-world treatment behavior. They couldn't distinguish providers who were actually treating patients from those who simply appeared in a directory.
The Approach
A new operating capability — not a better list
Bionara combined two complementary approaches to build complete visibility into the provider landscape.
Speed
Identify thousands of providers in days, not months. Systematic evaluation at a scale that manual research can't match.
Access
Reach previously invisible community treaters through AI-powered discovery that goes beyond traditional databases and directories.
Precision
Target based on real-world prescribing behavior — not assumptions about specialty. Know who is actually treating patients.
Results
The numbers speak for themselves
250K+
Providers evaluated
26K+
High-confidence targets identified
3
Disease spaces covered
Thousands
Hours of manual work saved
Before & After
What changed
Nobody else is doing it the way Bionara is doing it. I wouldn't even know how to begin tackling this if Bionara hadn't handled it for me.
— MSL Team Lead, Early Access Partner
The Outcome
From guesswork to full ecosystem visibility
The team moved from “who we think is treating patients” to “who is measurably treating patients at scale.” For the first time, they had a validated, scored view of the entire provider landscape — including community treaters who had never appeared on any list.
MSLs could now identify top providers driving real patient volume, expand engagement earlier in the patient journey, and operate with a level of speed, scale, and precision that wasn't possible before.
This wasn't a better list. It was a new capability.
See what Bionara can unlock for your team
Every therapeutic area has hidden providers your team isn't reaching yet.
Book a Demo